The US Department of Health and Human Services (HHS) is partnering with Sanofi Pasteur and Johnson & Johnson to develop vaccines and therapeutics to use against COVID-19, according to press releases from the drug makers and HHS today.
Sanofi announced it will be revisiting previous development work for a SARS (severe acute respiratory syndrome) vaccine to examine a path for COVID-19 vaccine development. Both SARS and COVID-19 are coronaviruses that originated in China, with SARS appearing in 2002 and largely disappearing by 2004.
The work will be done through a collaboration with the Biomedical Advanced Research and Development Authority (BARDA).
Sanofi said its vaccine will use a recombinant DNA platform to produce an exact genetic match to proteins found on the surface of the virus. According to Sanofi, the previous work on a SARS vaccine gives them a head start, as that vaccine candidate performed well in non-clinical studies and animal challenge models.
Read more at CIDRAP…
The post HHS partners with drug makers on COVID-19 vaccine, drugs appeared first on Healthier Environment Living Program.